Zecyte is a branded formulation of Abiraterone Acetate, manufactured by Cipla Ltd, India. It is an oral medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) in men. Abiraterone acetate works by selectively inhibiting the enzyme CYP17A1, which is essential for androgen production. Since androgens can promote the growth of prostate cancer cells, reducing their levels helps slow disease progression.his is typically used in combination with prednisone or prednisolone to help manage side effects related to hormone imbalance. It is recognized for its effectiveness and is a widely used treatment option in advanced stages of prostate cancer.
Category | Anti Cancer Drugs |
Brand | Cipla |
Ingredient | Abiraterone Acetate |
Prescription Required | Yes |
Strength | 250mg |
Package | 120 Tablets |
Zecyte 250 mg (Abiraterone acetate) works by targeting and inhibiting a specific enzyme in the body called CYP17A1, which is essential for the production of androgens, such as testosterone. These androgens play a key role in fueling the growth of prostate cancer cells, especially in cases of metastatic castration-resistant prostate cancer (mCRPC)—a form of prostate cancer that continues to progress despite low levels of testosterone.
Zecyte 250 mg (Abiraterone acetate) offers significant benefits in the treatment of metastatic castration-resistant prostate cancer (mCRPC). One of its primary advantages is its ability to effectively lower androgen levels in the body by inhibiting the CYP17A1 enzyme, which plays a crucial role in the production of testosterone and other male hormones that fuel prostate cancer growth. By drastically reducing these hormone levels, Zecyte helps to slow or halt the progression of cancer, alleviate related symptoms such as bone pain, and improve patients’ overall quality of life.
Often used as adjuvant therapy after tamoxifen or on its own.
The most common side effects of Zecyte 250mg are
Other side effects of Zecyte 250mg can include
Zecyte 250 mg (Abiraterone acetate) should not be taken by individuals who are allergic to Abiraterone or any of the ingredients in the medication, as this can lead to severe allergic reactions. It is strictly not recommended for use in women, especially pregnant or breastfeeding women, because it can cause serious harm to a developing fetus or infant.
Zecyte 250 mg (Abiraterone acetate) should be taken exactly as prescribed by your doctor, typically as four 250 mg tablets (1,000 mg) once daily. It must be taken on an empty stomach, at least 1 hour before or 2 hours after a meal, as food can increase the drug’s absorption and risk of side effects. The tablets should be swallowed whole with a glass of water—do not crush, chew, or break them.
There are no reviews yet.